We are live on
!
Find out more
APM
Avidity Partners Management Portfolio holdings
AUM
$936M
1-Year Est. Return
195%
This Fund
S&P 500
This Quarter
Est. Return
+13.95%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
–
AUM
$1.96B
AUM Growth
-$393M
(-17%)
Cap. Flow
-$554M
Cap. Flow
% of AUM
-28.28%
Top 10 Holdings %
Top 10 Hldgs %
32.05%
Holding
103
New
18
Increased
14
Reduced
37
Closed
22
Top Buys
| 1 |
UnitedHealth
UNH
|
+$49.4M |
| 2 |
Humana
HUM
|
+$46.2M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$26.7M |
| 4 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$26.1M |
| 5 |
ORKA
Oruka Therapeutics
ORKA
|
+$24.6M |
Top Sells
| 1 |
Cigna
CI
|
+$61M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$53.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$50.4M |
| 4 |
Avantor
AVTR
|
+$45.4M |
| 5 |
Intuitive Surgical
ISRG
|
+$45.1M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Boston Scientific
BSX
$64B
| $80.6M | 4.11% |
962,000
-208,100
| -18% | -$16.4M |
|
2
Dianthus Therapeutics
DNTH
$5.46B
| $79.9M | 4.07% |
2,917,231
| – | – |
|
|
3
Intuitive Surgical
ISRG
$138B
| $72.8M | 3.71% |
148,200
-96,800
| -40% | -$45.1M |
|
4
Natera
NTRA
$39.7B
| $70.6M | 3.6% |
556,400
-210,100
| -27% | -$24.1M |
|
5
CG Oncology
CGON
$6.44B
| $62.5M | 3.19% |
1,656,000
+359,775
| +28% | +$12.6M |
|
6
Acadia Healthcare
ACHC
$2.97B
| $62.5M | 3.19% |
985,000
-135,000
| -12% | -$9.75M |
|
7
Neurocrine Biosciences
NBIX
$17.3B
| $53M | 2.7% |
460,000
-31,000
| -6% | -$4.25M |
|
|
8
UnitedHealth
UNH
$380B
| $51.1M | 2.61% |
+87,400
| New | +$49.4M |
|
9
Jazz Pharmaceuticals
JAZZ
$15B
| $48M | 2.45% |
431,000
-113,500
| -21% | -$12.4M |
|
10
Syndax Pharmaceuticals
SNDX
$2.08B
| $47.3M | 2.41% |
2,455,000
-880,000
| -26% | -$18.2M |
|
11
Perspective Therapeutics
CATX
$367M
| $46M | 2.35% |
3,444,002
+406,334
| +13% | +$5.4M |
|
12
Glaukos
GKOS
$9.21B
| $44.9M | 2.29% |
344,900
+120,900
| +54% | +$15M |
|
13
IDEAYA Biosciences
IDYA
$3.54B
| $43.5M | 2.22% |
1,373,000
+256,000
| +23% | +$9.71M |
|
14
Insmed
INSM
$23.8B
| $43.2M | 2.2% |
592,000
+162,000
| +38% | +$12M |
|
15
Thermo Fisher Scientific
TMO
$199B
| $42.4M | 2.16% |
68,600
-11,400
| -14% | -$6.75M |
|
16
Tenet Healthcare
THC
$16.6B
| $42M | 2.15% |
253,000
-119,000
| -32% | -$18M |
|
17
Ultragenyx Pharmaceutical
RARE
$3.12B
| $41.8M | 2.13% |
752,000
-208,000
| -22% | -$10.6M |
|
|
18
Humana
HUM
$49B
| $41.1M | 2.1% |
+129,700
| New | +$46.2M |
|
|
EXAS
19
DELISTED
Exact Sciences
EXAS
| $40.1M | 2.04% |
588,000
+249,500
| +74% | +$14.1M |
|
20
Illumina
ILMN
$28.3B
| $38.1M | 1.94% |
292,000
-186,000
| -39% | -$22.9M |
|
21
Arvinas
ARVN
$534M
| $36.9M | 1.88% |
1,497,000
-1,490,845
| -50% | -$38.9M |
|
22
Revolution Medicines
RVMD
$39.2B
| $35.8M | 1.83% |
790,000
+35,000
| +5% | +$1.52M |
|
|
CNTA
23
DELISTED
Centessa Pharmaceuticals
CNTA
| $34.1M | 1.74% |
+2,132,000
| New | +$26.1M |
|
24
Phathom Pharmaceuticals
PHAT
$881M
| $32.6M | 1.66% |
1,804,493
+184,493
| +11% | +$2.58M |
|
25
Xenon Pharmaceuticals
XENE
$6.55B
| $32.2M | 1.64% |
818,000
+64,000
| +8% | +$2.58M |
|
Similar funds
NM
LM
IF
PWAM
CM
LJAC
PO
SH